Innovation Pharmaceuticals competitorsClear all
Innovation Pharmaceuticals's top competitors include Urovant Sciences, Heron Therapeutics, Thesan Pharmaceuticals and Immatics.
| Save Comparison |  Innovation Pharmaceuticals Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications. |  Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions. |  Heron Therapeutics Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. |  Thesan Pharmaceuticals Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |
Founding Date | Founding Date 2007 | Founding Date 2016 | Founding Date 1983 | Founding Date 2011 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Wakefield, US HQ Beverly, US | Locations Irvine, US HQ Basel, CH | Locations San Diego, US HQ Jersey City, US | Locations Carlsbad, US HQ | Locations Tübingen, DE HQ München, DE Houston, US |
Employees | Employees 450% decrease | Employees 3950% increase | Employees 23117% increase | Employees 1 | Employees 230 |
Valuation ($) | Valuation ($) 134.5 m | Valuation ($) 529.5 m | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) 705.2 m |
Twitter followers | Twitter followers 180 | Twitter followers 115 | Twitter followers N/A | Twitter followers N/A | Twitter followers 1.1 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 17 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.1 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 4.4 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 226808 | Alexa Website Rank 450870 | Alexa Website Rank 354402 | Alexa Website Rank 363256 | Alexa Website Rank 252172 |
Financial | |||||
Revenue (est.) | Revenue (est.) $423k (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $88.6m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €18.4m (FY, 2019) |
Net income | Net income ($6.6m) (FY, 2020) | Net income ($146.7m) (FY, 2020) | Net income ($227.3m) (FY, 2020) | Net income N/A | Net income (€32.5m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 65m | Total funding raised $ 267.3m |
For sources of this data, please see the company profile
View company profiles
Urovant Sciences
HQ
Irvine, US
Employees
39↑ 50% increase
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
231↑ 17% increase
Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
View companyThesan Pharmaceuticals
HQ
Carlsbad, US
Employees
1
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
View companyImmatics
HQ
Tübingen, DE
Employees
230
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company